L-NMMA (a Nitric Oxide Synthase Inhibitor) is Effective in the Treatment of Cardiogenic Shock
- 28 March 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 101 (12) , 1358-1361
- https://doi.org/10.1161/01.cir.101.12.1358
Abstract
Background—The objective was to assess the safety and efficacy of L-NMMA in the treatment of cardiogenic shock. Methods—We enrolled 11 consecutive patients with cardiogenic shock that persisted aft...Keywords
This publication has 4 references indexed in Scilit:
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic ShockNew England Journal of Medicine, 1999
- Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flowThe Annals of Thoracic Surgery, 1998
- Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedemaThe Lancet, 1998
- Increased production of nitric oxide in coronary arteries during congestive heart failure.Journal of Clinical Investigation, 1994